
Bioarise Pharmaceuticals Limited
About Bioarise Pharmaceuticals Limited
Data last updated:
Bioarise Pharmaceuticals Limited was a public limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the business services sector. It was incorporated on 18 November 2016.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PLC308340. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Arise Pharmaceuticals Limited. It was led by directors including Prithvi Raj Saigal and Sunil Malhotra.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 105 First Floor H – 10 Express Arcade Netaji Subhash Place Pitampura, Delhi, India – 110034.
Company details
Contact details
Bioarise Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address105 First Floor H – 10 Express Arcade Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Bioarise Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bioarise Pharmaceuticals Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Bioarise Pharmaceuticals Limited, buy the company report.
Board of directors of Bioarise Pharmaceuticals Limited
Bioarise Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Malhotra Also directs: Ams Infra Hospitality LLP, DSR Path Labs LLP, Sheer Serenity Private Limited and 5 more | Additional Director | 22 Feb 2017 | 9 Years 8 Months | As last reported |
| Abhishek Jain Also directs: Arise Medical International Limited | Additional Director | 06 Apr 2017 | 9 Years 6 Months | As last reported |
| Prithvi Raj Saigal | Director | 18 Nov 2016 | 9 Years 11 Months | As last reported |
Auditor
Bioarise Pharmaceuticals Limited is audited by ANIL KUMAR AGGARWAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANIL KUMAR AGGARWAL | FY 2017 | 095298 |
Shareholding
The shareholding of Bioarise Pharmaceuticals Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Bioarise Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bioarise Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bioarise Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bioarise Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bioarise Pharmaceuticals Limited, buy the company report.
Recent activity
Bioarise Pharmaceuticals Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Sunil Malhotra ceased to be Additional Director on 17 Feb 2018.
Frequently asked questions
Bioarise Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Bioarise Pharmaceuticals was a public limited company based in Delhi, India. The company worked in other services, within the business services industry. It was incorporated on 18 November 2016 and is registered under CIN U74999DL2016PLC308340. The company has been struck off by the Registrar of Companies and is no longer operational.
Bioarise Pharmaceuticals had 3 directors:
- Sunil Malhotra - Additional Director
- Abhishek Jain - Additional Director
- Prithvi Raj Saigal - Director
The CIN (Corporate Identification Number) of Bioarise Pharmaceuticals is U74999DL2016PLC308340. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Bioarise Pharmaceuticals is at 105 First Floor H – 10 Express Arcade Netaji Subhash Place Pitampura, Delhi, India – 110034.
Bioarise Pharmaceuticals was incorporated on 18 November 2016. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Bioarise Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from FY 2017 are in the company report.
No. Bioarise Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Bioarise Pharmaceuticals operated in the business services industry, in the other services segment. It worked in this industry before it was struck off.
Sunil Malhotra ceased to be Additional Director on 17 Feb 2018. Abhishek Jain was appointed as Additional Director on 06 Apr 2017. Ishani Saigal ceased to be Director on 06 Apr 2017. Bioarise Pharmaceuticals has 7 board changes on record in total.

